Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3002 (recombinant human growth hormone) in children with idiopathic short stature
KCT0000896Phase 3Active, not recruiting
- Sponsor
- Dong-A ST
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Growtropin-II in Idiopathic Short Stature (ISS), sponsored by Dong-A ST. Started Feb 2012; status: active, not recruiting.
02
Drugs
Growtropin-II
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on KCT0000896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000896.